Evidence-based Appraisal Research of Traditional Chinese External Tazi Therapy with Fufang Huangbai Ye to Control Diabetic Foot Ulcer with Drug-resistant Bacteria

Dongzhimen Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Patients meeting the diagnostic criteria of diabetic foot;
•2. Patients with IDSA grade 2;
•3. Culture confirmed the bacteriological basis, and the wound was infected by drug-resistant bacteria;
•4. Patients with HbA1c <= 8%;
•5. Patients between 18 and 75 years old, male or female;
•6. Patients with ABI >= 0.4;
•7. Patients with wound area between 1 cm x 1cm and 10 cm x 10cm;
•8. Patients who voluntarily participated in the trial and signed the informed consent.

•1. Patients allergic to compound Phellodendron solution and silver ion antibacterial dressing;
•2. Patients who used antibiotics in any way within one week before treatment;
•3. Serious heart, liver and kidney dysfunction, which seriously affect the safety and treatment of the subjects, should be ruled out by the researchers;
•4. Patients with foot ulcer caused by venous, tumor, radiation, simple arterial and other non-diabetic reasons.
•5. Patients with serum albumin < 25g / L;
•6. Patients with hemoglobin < 90g / L;
•7. Patients whose platelets are lower than the lower limit of normal value;
•8. Subjects with pregnancy or birth planning, or pregnant or lactating women;
•9. Patients with cognitive impairment can not give full informed consent;
•10. Patients with allergic constitution or known hypersensitivity to the components of test drug and control drug;
•11. Patients who participated in other clinical trials in recent one month;
•12. According to the judgment of the researcher, the patient was unable to complete the study or comply with the requirements of the study.

发起方

Dongzhimen Hospital, Beijing University of Chinese Medicine